PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 18, 2026Current Topics in Medicinal Chemistry0 citations

Emerging Multi-Target Therapies for Type 2 Diabetes: Bridging Drug Innovation and Precision Delivery

View Full Paper
PSPriya SinghalRMRupa MazumderARAnjna Rani

Key Points

  • The aim is to explore emerging multi-target therapies and their role in enhancing diabetes management.
  • Review of recent literature on drug delivery systems and multi-target therapies for diabetes
  • Analysis of specific targets like AMPK and GLP-1
  • Evaluation of therapeutic strategies improving glycemic control
  • Multi-target therapies show improved glycemic control compared to traditional treatments
  • Enhanced drug delivery systems improve therapeutic efficacy and reduce side effects
  • Identified several novel targets for drug development, including SGLT2 inhibitors and PPAR-γ modulators

Abstract

Abstract: Diabetes is a long-term metabolic disorder characterized by elevated blood glucose levels and is primarily classified into Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM). Conventional drug delivery systems often face limitations such as low bioavailability, inadequate target specificity, and the need for frequent dosing. Drug targeting offers significant advantages in diabetes treatment by enhancing therapeutic efficacy and reducing side effects. This is achieved by binding drug-loaded carriers to specific receptors on insulin-sensitive tissues or pancreatic β-cells, ensuring precise action at the disease site and improving patient compliance. Several therapeutic targets have been identified to improve glycemic control and overcome the limitations associated with traditional drug delivery approaches. The present study provides insights into emerging targets for diabetes management, including AMPK (AMP-Activated Protein Kinase), glucose absorption inhibitors, renal glucose reabsorption inhibitors, GLP-1 (Glucagon- Like Peptide-1) agonists, SGLT2 (Sodium-Glucose Cotransporter-2) inhibitors, and PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) modulators. Increasing attention is also being given to multi-targeted therapy, which simultaneously modulates multiple interconnected physiological pathways involved in diabetes pathogenesis. Such strategies have demonstrated the potential to improve glycemic control, reduce long-term complications, and offer better safety profiles compared to monotherapy. Given the multifactorial nature of diabetes, a combination of precisionbased and multi-targeted approaches holds promise for developing safer, better tolerated, and patient- centered antidiabetic therapies. This review highlights recent advances in identifying novel therapeutic targets and drug delivery strategies, contributing to the evolving paradigms that may shape the future of diabetes care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Singhal et al. (2026) studied this question.

synapsesocial.com/papers/696c77d4eb60fb80d1396085https://doi.org/10.2174/0115680266429073251122045133
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Precision Medicine Approaches in Diabetes Management: Targeting Individualized Pathways2024
  2. 2From Current Therapeutics to Multitarget Ligands: A Review of Diabetes Pharmacological Treatments2025 · 8 citations
  3. 3Search for Novel Therapeutic Targets of Type 2 Diabetes Mellitus2024 · 2 citations
  4. 4Current Situation on Diabetes Management: New Weapons Fighting the Disease in 20252025 · 1 citations
  5. 5Emerging Technologies and Innovative Therapeutic Strategies for Diabetes Management2026